Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Population Diagnostics, Inc. Company Profile

07:54 EDT 1st August 2014 | BioPortfolio

Population Diagnostics, Inc. (PDx, www.populationdiagnostics.com) is applying its discoveries in human genetics to the development of DNA-based diagnostics and personalized medicine tests. PDx’s technology, which reveals the genetic causes of complex diseases such as autism, diabetes, Parkinson’s, and Alzheimer’s, enables development of early detection diagnostic tests that predict pre-symptomatically why some individuals will suffer from debilitating diseases while others will not. When applied to drug discovery, the technology enables pharmaceutical companies to develop targeted therapies and companion diagnostics. Its novel technology and exclusive products places PDx in a prime position to (i) transform how physicians diagnose and manage disease in their patients and (ii) enable pharmaceutical companies to expand the number of available therapies and market drugs with higher efficacy and safety.


News Articles [721 Associated News Articles listed on BioPortfolio]

International Veterinary Diagnostics (Clinical Chemistry, Hematology Analyzers, Molecular Diagnostics, Immunodiagnostics, Diagnostics Imaging) Market - Forecasts to 2018

Dublin, July 1, 2014 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/pfmv2h/veterinary)  has announced the addition of the "International Veterinary Diagnostics...

AstraZeneca Partners with Roche on Development of a Companion Diagnostic

The topic of companion diagnostics has been of continuing interest for me. I have posted a number of notes about this type of lab test (see, for example: More Details About Roche's Companion Diagnosti...

Veterinary Diagnostics Market by Products (Clinical Chemistry, Hematology Analyzers, Molecular Diagnostics, Immunodiagnostics, Diagnostics Imaging), by Animals (Companion, Food-producing, Dog, Livestock, Poultry, Swine) - Global Forecast to 2018

Over the years, the veterinary diagnostics market has grown multi-fold, adapting various technologies from the human diagnostics segment. In the past decade, a number of new products have been launche...

EKF Molecular Diagnostics to exhibit PointMan DNA-enrichment technology at Tri-Con 2014

EKF Diagnostics, the global in vitro diagnostics business, announces that its subsidiary company EKF Molecular Diagnostics is exhibiting its ground-breaking PointMan DNA-enrichment technology at Tri-C...

MGC Diagnostics to acquire Medisoft

MGC Diagnostics, a global medical technologies company, has entered into a letter of intent to acquire Medisoft of Sorinnes, Belgium. MGC Diagnostics would acquire all the outstanding shares of Mediso...

Leading Commentary on Molecular Diagnostics Edited by LGC Expert

The application of molecular technology in clinical diagnosis is a rapidly developing area and is predicted to greatly improve the speed, efficiency and accuracy of diagnostic medicine. A book looking...

Easy-to-use companion diagnostics draw Abbott, Biocartis into joint development deal

Belgo-Swiss molecular diagnostics developer Biocartis and US healthcare products maker Abbott Laboratories (NYSE:ABT) will jointly develop and market multiplex companion diagnostics tests, combining B...

Autoimmune epilepsy diagnostics: an interview with Dr. Joseph J. Higgins, Medical Director, Neurology, Athena Diagnostics, a business of Quest Diagnostics

Epilepsy is a group of neurological disorders often characterized by seizures and cognitive impairment due to electrical disturbances in the brain.

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]

Oxygen

Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [1409 Associated PubMed Articles listed on BioPortfolio]

Point-of-Care Diagnostics in Low-Resource Settings and Their Impact on Care in the Age of the Noncommunicable and Chronic Disease Epidemic.

The emergence of point-of-care (POC) diagnostics specifically designed for low-resource settings coupled with the rapid increase in need for routine care of patients with chronic diseases should promp...

The difficulties encountered in diagnostics of malignant neoplasms of the middle ear in the children.

The objective of the present work was to estimate the potential of CT and MRI diagnostics of malignant neoplasms of the middle ear in the children. Diagnostics of these tumours encounters great diffic...

Structured diagnostics and therapy of the CUP syndrome.

In the majority of cases, patients with cancer of unknown primary (CUP) have a poor prognosis with no prospect of being cured. Hence, a reasonable focus of diagnostics on its essential targets seems a...

Saliva and Biofilm-based Diagnostics: A Critical Review of the Literature Concerning Sialochemistry.

There is some evidence to support the use of salivary diagnostics in dentistry.

Integrating molecular diagnostics into histopathology training: the Belfast model.

Molecular medicine is transforming modern clinical practice, from diagnostics to therapeutics. Discoveries in research are being incorporated into the clinical setting with increasing rapidity. This t...

Clinical Trials [850 Associated Clinical Trials listed on BioPortfolio]

BRADYCARE: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes

Pacemaker technology is constantly evolving. In the past 10 years, numerous advancements have been made in pacemaker therapy, diagnostics and connectivity. These advancements include autom...

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of...

Diagnostics and Therapy of Disease-Related Quality of Life of Patients With Breast Cancer

Quality of Life-Diagnostics and -Therapy in Individual Patients with Breast Cancer. A randomized study including 200 patients, 5 clinics and 43 general practitioners as coordinating docto...

Implementation of Quality of Life Diagnostics and Therapy

Implementation and Evaluation of Implementation of Quality of Life Diagnostics and Therapy in Individual Patients with Breast Cancer. A prospective study including 170 patients, 5 clinics...

Clinical Sensitivity of Clearview Rapid Tests in 12-17 y/o Pediatric Population

This study is to establish the clinical sensitivity of the Chembio Diagnostics Systems, Inc. Clearview COMPLETE HIV 1/2 Assay and Clearview HIV 1/2 Stat-Pak Assay (Clearview HIV tests) in...

Companies [1048 Associated Companies listed on BioPortfolio]

Population Genetics Technologies Ltd

Population Genetics Technologies Ltd was founded in 2005 by Nobel Laureate Dr Sydney Brenner; by Dr Sam Eletr, a founder of Applied Biosystems and of Lynx Therapeutics; and by Dr...

Veterinary Diagnostics Institute (VDxI), Inc.

VDxI, a California corporation, is a veterinary clinical ventures company dedicated to the introduction of innovative biomarkers for companion animals. Through collaboration with...

Population Diagnostics, Inc.

Population Diagnostics, Inc. (PDx, www.populationdiagnostics.com) is applying its discoveries in human genetics to the development of DNA-based diagnostics and personalized medici...

Quintiles and Population Genetics Technologies Ltd.

Co-founded by Nobel Laureate Dr. Sydney Brenner, Population Genetics Technologies creates products that accelerate large-scale population studies, through the simultaneous analysi...

Sekisui Diagnostics

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices...

More Information about "Population Diagnostics, Inc." on BioPortfolio

We have published hundreds of Population Diagnostics, Inc. news stories on BioPortfolio along with dozens of Population Diagnostics, Inc. Clinical Trials and PubMed Articles about Population Diagnostics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Population Diagnostics, Inc. Companies in our database. You can also find out about relevant Population Diagnostics, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Relevant Topics

Neurology - Central Nervous System (CNS)
Latest News Clinical Trials Research Drugs Reports Corporate
Neurology is the branch of medicine concerned with nerves; both the central nervous system and the peripheral nervous system. This includes strokes and disorders affecting the brain aswell as spinal cord damage and peripheral neuropathies.The complexity...

Diabetes
Latest News Clinical Trials Research Drugs Reports Corporate
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record